In a joint statement, the American Society of Hematology, the American Association for Cancer Research, the Association of American Cancer Institutes, the American Society for Radiation Oncology, the American Society of Pediatric Hematology/Oncology, and the LUNGevity Foundation expressed concern over the immigration executive order signed by President Donald Trump and his administration.
“Our nation depends on the contributions of the greatest minds from around the world to maintain the high quality of our biomedical research enterprise and health care services,” the statement reads. “The benefits of scientific collaborations are amplified by our diversity. Limiting the exchange of ideas, practices, and data across cultures has the potential to significantly retard scientific progress and adversely affect public health.”
The statement also notes that travel restrictions will prohibit participation at scientific meetings that draw health-care providers from all over the world to advance collaboration and information sharing.
“We respectfully call on the administration to consider the negative impact of its executive order on our nation’s ability to attract the world’s best scientific and clinical talent to participate in the fight against cancer and blood diseases, irrespective of their country of origin,” the statement concludes.
Source: American Society of Hematology press release, February 1, 2017.